Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 3
1984 2
1987 1
1990 1
1991 1
1992 2
1993 4
1994 2
1995 1
1996 3
1997 3
1998 1
1999 3
2000 1
2001 1
2002 7
2005 4
2006 2
2007 1
2008 1
2010 1
2011 2
2012 4
2013 3
2014 5
2015 3
2016 1
2017 2
2018 6
2019 3
2020 2
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.
von Minckwitz G, Schneeweiss A, Loibl S, Salat C, Denkert C, Rezai M, Blohmer JU, Jackisch C, Paepke S, Gerber B, Zahm DM, Kümmel S, Eidtmann H, Klare P, Huober J, Costa S, Tesch H, Hanusch C, Hilfrich J, Khandan F, Fasching PA, Sinn BV, Engels K, Mehta K, Nekljudova V, Untch M. von Minckwitz G, et al. Among authors: salat c. Lancet Oncol. 2014 Jun;15(7):747-56. doi: 10.1016/S1470-2045(14)70160-3. Epub 2014 Apr 30. Lancet Oncol. 2014. PMID: 24794243 Clinical Trial.
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.
Loibl S, Weber KE, Timms KM, Elkin EP, Hahnen E, Fasching PA, Lederer B, Denkert C, Schneeweiss A, Braun S, Salat CT, Rezai M, Blohmer JU, Zahm DM, Jackisch C, Gerber B, Klare P, Kümmel S, Schem C, Paepke S, Schmutzler R, Rhiem K, Penn S, Reid J, Nekljudova V, Hartman AR, von Minckwitz G, Untch M. Loibl S, et al. Among authors: salat ct. Ann Oncol. 2018 Dec 1;29(12):2341-2347. doi: 10.1093/annonc/mdy460. Ann Oncol. 2018. PMID: 30335131 Free article. Clinical Trial.
[Chronic myeloid leukemia--treatment].
Stoetzer OJ, Hentrich M, Salat C. Stoetzer OJ, et al. Among authors: salat c. Dtsch Med Wochenschr. 2002 Dec 6;127(49):2621-4. doi: 10.1055/s-2002-35948. Dtsch Med Wochenschr. 2002. PMID: 12469275 Review. German. No abstract available.
[Chronic myeloid leukemia--pathophysiology and diagnosis].
Stoetzer OJ, Hentrich M, Salat C. Stoetzer OJ, et al. Among authors: salat c. Dtsch Med Wochenschr. 2002 Dec 6;127(49):2618-20. doi: 10.1055/s-2002-35947. Dtsch Med Wochenschr. 2002. PMID: 12469274 Review. German. No abstract available.
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.
Furlanetto J, Möbus V, Schneeweiss A, Rhiem K, Tesch H, Blohmer JU, Lübbe K, Untch M, Salat C, Huober J, Klare P, Schmutzler R, Couch FJ, Lederer B, Gerber B, Zahm DM, Bauerfeind I, Nekljudova V, Hanusch C, Jackisch C, Link T, Hahnen E, Loibl S, Fasching PA. Furlanetto J, et al. Among authors: salat c. Eur J Cancer. 2021 Mar;145:44-52. doi: 10.1016/j.ejca.2020.12.007. Epub 2021 Jan 7. Eur J Cancer. 2021. PMID: 33423006
[Metastatic breast cancer--new methods of treatment].
Rack B, Heinemann V, Schindlbeck C, Walther J, Salat C, Sommer H. Rack B, et al. Among authors: salat c. MMW Fortschr Med. 2008 Jan 17;150(1-2):34-6. doi: 10.1007/BF03365276. MMW Fortschr Med. 2008. PMID: 18300641 Review. German. No abstract available.
[Chronic myeloid leukemia--case report].
Hentrich M, Stoetzer OJ, Salat C, Ledderose G. Hentrich M, et al. Among authors: salat c. Dtsch Med Wochenschr. 2002 Dec 6;127(49):2617. doi: 10.1055/s-2002-35924. Dtsch Med Wochenschr. 2002. PMID: 12469273 German. No abstract available.
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.
Stoetzer O, Di Gioia D, Issels RD, Abdel-Rahman S, Mansmann U, Lindner LH, Gluz O, Würstlein R, Braun M, Hamann M, Edler von Koch F, Harbeck N, Salat C. Stoetzer O, et al. Among authors: salat c. Breast Care (Basel). 2021 Apr;16(2):173-180. doi: 10.1159/000507473. Epub 2020 May 12. Breast Care (Basel). 2021. PMID: 34012372 Free PMC article.
74 results